Article Information
History
- July 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hannah M. Korevaar1,*,
- Alexander D. Becker2,
- Ian F. Miller2,
- Bryan T. Grenfell2,5,6,
- C. Jessica E. Metcalf2,5 and
- Michael J. Mina3,4
- 1Office of Population Research, Princeton University, NJ, USA
- 2Department of Ecology and Evolutionary Biology, Princeton University, NJ, USA
- 3Center for Communicable Disease Dynamics, Department of Epidemiology and Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, MA, USA
- 4Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, MA, USA
- 5Princeton School of Public and International Affairs, Princeton University, NJ, USA
- 6Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, MD, USA
- ↵* Corresponding author; email: hannah.korevaar{at}gmail.com
Posted July 01, 2020.
Quantifying the impact of US state non-pharmaceutical interventions on COVID-19 transmission
